Larimar Therapeutics (LRMR) Q2 2025 Earnings

Apr 30Confirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-0.46
-0.39
-0.31
-0.24

Details

Expected EPS
-0.418251
Actual EPS
-0.46
Surprise EPS
-0.04
Surprise Percent
-9.98%

Description

⁨Larimar Therapeutics⁩ (⁦LRMR⁩) has reported earnings of ⁦-0.46⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts